
GC73188
SFI003
Also known as N-[(E)-1-(1H-benzimidazol-2-yl)ethylideneamino]-4-(4-methoxyphenyl)-1,3-thiazol-2-amine
SFI003 is a SRSF3 inhibitor that drives CRC cell apoptosis via the SRSF3/DHCR24/ROS axis and exhibits potent antitumor effects both in vitro and in vivo
ChemicalCAS2361332-90-1MW363.44FormulaC19H17N5OS
- CAS number
- 2361332-90-1
- Molecular weight
- 363.44
- Formula
- C19H17N5OS
- Solubility
- DMSO : 125 mg/mL (343·94 mM; Need ultrasonic)
- InChIKey
- QGFYENXFCHRFJF-FSJBWODESA-N
- Catalogue number
- GC73188
- Brand
- GLPBIO
Computed properties PubChem CID 141745171 · XLogP 4.7 · TPSA 103 Ų · H-bond donors 2
- XLogP
- 4.7
- TPSA
- 103 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 26
SMILES C/C(=N\NC1=NC(=CS1)C2=CC=C(C=C2)OC)/C3=NC4=CC=CC=C4N3
Computed descriptors from PubChem (CID 141745171), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il